Healthcare -
Biotechnology - NASDAQ - US
$ 1.33
0 %
$ 2.71 M
Market Cap
-0.1
P/E
DRMA - STOCK-BASED COMPENSATION
Stock-based Compensation DRMA - Dermata Therapeutics, Inc.
522 K
LAST VALUE
-47.65%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR